Month: February 2022

Stockholm, 22 februari 2022 Bokslutskommuniké för perioden 2021-01-01 – 2021-12-31, Svensk Hypotekspension Fond 4 AB (publ) Bokslutskommunikén finns tillgänglig på bolagets hemsida under “Finansiell Information”, eller via Svensk Hypotekspension Fond 4 AB (publ) – Bokslutskommunike – 211231 För ytterligare information, vänligen kontakta:Anders Larsson, CEO på Svensk Hypotekspension AB Telefon: 08-586 160 11 E-post: anders.larsson@hypotekspension.seViktig informationDenna information är sådan information som Svensk Hypotekspension Fond 4 AB (publ) är skyldig att offentliggöra enligt lag om värdepappersmarknaden. Denna information tillgängliggjordes för offentliggörande genom kontaktpersonen ovan klockan 15.00 CET den 22 februari 2022.AttachmentSvensk Hypotekspension Fond 4 AB (publ)...

SALEM, Ind., Feb. 22, 2022 (GLOBE NEWSWIRE) — Mid-Southern Bancorp, Inc. (the “Company”) (NASDAQ: MSVB), the holding company for Mid-Southern Savings Bank, FSB (the “Bank”), reported net income for the fourth quarter ended December 31, 2021 of $377,000 or $0.13 per diluted share compared to $200,000 or $0.07 per diluted share for the same period in 2020. For the year ended December 31, 2021, the Company reported net income of $1.6 million or $0.55 per diluted share compared to $1.2 million or $0.38 per diluted share for the same period in 2020. In light of the events surrounding the COVID-19 pandemic, the Company is continually assessing the effects of the pandemic to its employees, customers and communities. In March 2020, the Coronavirus Aid, Relief, and Economic Security Act (the “CARES Act”) was enacted. The CARES Act contains...

SEATTLE, Feb. 22, 2022 (GLOBE NEWSWIRE) — via NewMediaWire – 3DX Industries, Inc. (DDDX) (the “Company” or “3DX”), a state of the art additive manufacturer specializing in 3D Metal Printing, announces it has filed it’s Annual Report on otcmarkets.com for the period ending October 31, 2021. The Annual Report showcases the company’s performance from November 1, 2020, to October 31, 2021. The Annual Report identifies some of the company’s growth over the past year, including the following key highlights:Total Assets increased: The Company reported Total Assets of $2.26 million, up from $253,000 the year before.  Cash balance increased: The Company reported $680,000 in cash at the end of the reporting period, up from the previous reporting period, increasing its current asset position. Accounts receivables increased: The Company...

First Quarter Revenues Increase 21% to $10.7 Million Brooklyn, NY, Feb. 22, 2022 (GLOBE NEWSWIRE) —  – Cemtrex Inc. (NASDAQ: CETX, CETXP), a technology company driving innovation in Internet of Things (IoT), security, machine vision & artificial intelligence, and augmented & virtual reality, has reported its financial and operational results for the first quarter ended December 31, 2021. Key First Quarter 2022 and Subsequent HighlightsRevenue increased 21% to $10.7 million compared to $8.8 million in Q1’21. Regained compliance with Nasdaq Audit Committee composition requirements. Appointed independent directors Chris Wagner, a technology expert in the video internet streaming industry, and Manpreet Singh, CFA, founder and Chief Investment Officer of Singh Capital Partners, to the Board of Directors. Initiated...

Uponor Corporation     Stock exchange release     22 February 2022     15:15 EET Uponor Corporation’s Annual Review 2021 published Uponor Corporation’s Annual Review 2021 has been published today. The Annual Review consists of information for shareholders, Report by the Board of Directors, consolidated financial statements, parent company financial statements and Auditor’s report. In accordance with European Single Electronic Format (ESEF) reporting requirements, Uponor publishes the Annual Review as an XHTML file. In line with the ESEF requirements, the primary statements of the consolidated financial statements have been labelled with XBRL markups. The audit firm KPMG has provided an independent auditor’s reasonable assurance report on Uponor’s ESEF Consolidated Financial Statements in accordance with ISAE 3000. The Annual Review...

– ARCALYST® (rilonacept) net revenue of $18.7 million in Q4 2021 and $38.5 million in 2021 –– ARCALYST collaboration achieved profitability in Q4 2021 –– ARCALYST full-year 2022 net revenue expected to be $115 – $130 million –– Strategic collaboration with Huadong Medicine to develop and commercialize ARCALYST and mavrilimumab in the Asia Pacific Region (excluding Japan) –– Conference call and webcast scheduled for 8:30 am ET today – HAMILTON, Bermuda, Feb. 22, 2022 (GLOBE NEWSWIRE) — Kiniksa Pharmaceuticals, Ltd. (Nasdaq: KNSA) (“Kiniksa”), a biopharmaceutical company with a portfolio of assets designed to modulate immunological pathways across a spectrum of diseases, today reported fourth quarter and full-year 2021 financial results and provided a corporate update. “The successful launch of ARCALYST in recurrent pericarditis...

ATLANTA, GA, Feb. 22, 2022 (GLOBE NEWSWIRE) — via NewMediaWire — Avra, Inc. (OTC PINK: AVRN), operating as Springs Rejuvenation, (“Springs”), a Chamblee, Georgia based anti-aging and stem cell center focusing on stem cell therapy, announced today a +200% increase in their 4th quarter earnings compared to the 3rd quarter. This is a substantial increase nearly matching All of the 3 previous quarters’ earnings combined, and strong growth is expected to continue. Avra’s annual report, filed on OTC Markets, shows a strong uptick of the company’s earnings post-merger.  CEO Everett Dickson is quoted as saying, “It’s clear our marketing efforts are beginning to bear fruit. We have been retooling our digital footprint, beta testing several Google ads and launching a ‘boots on the ground’ campaign to increase the recognition of our...

Development Map Development MapCALGARY, Alberta, Feb. 22, 2022 (GLOBE NEWSWIRE) — (PIPE – TSX) Pipestone Energy Corp. (“Pipestone” or the “Company”) is pleased to provide an update on its operations with record quarterly production achieved; and to report its year-end 2021 independent reserves evaluation prepared by McDaniel & Associates Consultants Ltd. (“McDaniel”) with an effective date of December 31, 2021 (the “McDaniel Report”). Recent Operations Highlights:Record Production Volumes: Q4 2021 production averaged 28,623 boe/d (30% condensate, 44% total liquids), the highest quarterly production since inception. Production during Q4 2021 was impacted by several cold weather-related outages at 3rd party midstream facilities; 2021 Production Guidance Achieved: 2021 production averaged 24,584 boe/d(1) (31% condensate,...

– Company experiencing improved sales momentum from proprietary products – CARLSBAD, Calif., Feb. 22, 2022 (GLOBE NEWSWIRE) — Aurora Spine Corporation (“Aurora Spine” or the “Company”) (TSXV: ASG) (OTCQB: ASAPF), a designer and manufacturer of innovative medical devices that improve spinal surgery outcomes, today announced a business update for investors and preliminary, unaudited revenue results for the fourth quarter and fiscal year ended December 31, 2021. Business and Financial HighlightsThe Company expects revenues for the fourth quarter and FY21 to show an increase of about 23% over both the comparable prior year periods at approximately $3.0 million for Q4, and over $10.5 million for the year. Sales of ZIP® products were up 145% in 2021. Sales of SiLO™ SI Joint fusion devices comprised...

– Unprecedented CLEAR Outcomes Study Achieved 90% MACE Accumulation in February 2022 – – U.S. Net Product Revenue of NEXLETOL® (bempedoic acid) Tablets and NEXLIZET® (bempedoic acid and ezetimibe) Tablets Grew 12% Sequentially to $12.2 Million in the Fourth Quarter 2021 and Over 200% for the Full Year 2021 – – Prescriptions Grew 9% During the Quarter; Approximately 70,000 Patients Have Filled a Prescription for NEXLETOL Tablets or NEXLIZET Tablets Since Launch – – Strengthened Capital Position in Fourth Quarter 2021 with $209 Million Financing Securing Path to CLEAR Outcomes Topline and Beyond – ANN ARBOR, Mich., Feb. 22, 2022 (GLOBE NEWSWIRE) — Esperion (NASDAQ: ESPR) today reported financial results for the fourth quarter and full year ended December 31, 2021 and provided a business update. “In 2021, Esperion strengthened its...